Provided by Tiger Fintech (Singapore) Pte. Ltd.

PainReform

2.77
-0.0500-1.77%
Post-market: 2.770.00000.00%17:49 EDT
Volume:24.31K
Turnover:66.98K
Market Cap:2.42M
PE:-0.02
High:2.83
Open:2.78
Low:2.70
Close:2.82
Loading ...

PainReform Ltd trading halted, volatility trading pause

TIPRANKS
·
20 Dec 2024

Crude Oil Edges Lower; US Initial Jobless Claims Increase

Benzinga
·
06 Dec 2024

Wall Street Set to Open Flat Thursday; Initial Jobless Claims Higher Than Expected

MT Newswires Live
·
05 Dec 2024

Investors Await Jobless Claims Data as Markets Tread Water in Thursday's Premarket

MT Newswires Live
·
05 Dec 2024

PainReform Shares Rise 49% on Compliance With Nasdaq Listing Rules

Dow Jones
·
05 Dec 2024

PainReform Ltd. Navigates Leadership Changes and Nasdaq Compliance

TIPRANKS
·
05 Dec 2024

PainReform - Nasdaq Notified Co It Has Regained Compliance With Minimum Bid Price Requirement

THOMSON REUTERS
·
05 Dec 2024

PainReform Ltd expected to post a loss of $18.96 a share - Earnings Preview

Reuters
·
29 Nov 2024

PainReform (PRFX) Receives a Hold from Maxim Group

TIPRANKS
·
22 Nov 2024

PainReform Ltd trading halted, news pending

TIPRANKS
·
21 Nov 2024

Nasdaq Tumbles Over 100 Points; TJX Earnings Top Views

Benzinga
·
21 Nov 2024

PainReform's Shares Tumble After Data Issue Muddles Late-Stage Study of Non-Opioid Pain Treatment

MT Newswires Live
·
20 Nov 2024

PainReform drops on late-stage trial data for post-surgical pain management after bunionectomy

seekingalpha
·
20 Nov 2024

PainReform announces data for PRF-110 Phase 3 trial, notes incoherence of data

TIPRANKS
·
20 Nov 2024

BRIEF-PainReform Announces Initial Topline Data For PRF-110 Phase 3 Clinical Trial

Reuters
·
20 Nov 2024

PainReform Announces Initial Topline Data for Prf-110 Phase 3 Clinical Trial

THOMSON REUTERS
·
20 Nov 2024